Fundraising FoxAlp Bio
2 known investors
Find your way into Alp Bio
Sign up to see every warm intro you have to Alp Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alp Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alp Bio operates a platform that combines human tonsil organoid technology with protein AI models to assess and reduce immunogenicity (anti-drug antibody) risk in therapeutic antibodies before clinical development. It serves biologics developers with in-silico ADA screening, ex vivo tonsil organoid assays, and generative redesign of antibody sequences.
Founders & leadership
Investors · 2
42CAPlisted by 42CAPBerlin · $550K – $3.3M
How we know: 42CAP's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Venture KickreportedSchlieren-Zürich
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Alp Bio do?
- Alp Bio operates a platform that combines human tonsil organoid technology with protein AI models to assess and reduce immunogenicity (anti-drug antibody) risk in therapeutic antibodies before clinical development. It serves biologics developers with in-silico ADA screening, ex vivo tonsil organoid assays, and generative redesign of antibody sequences.
- Who founded Alp Bio?
- Alp Bio was founded by Anatol Ehrlich.
- Who are Alp Bio's investors?
- Alp Bio's investors include 42CAP, Venture Kick.